-
From CBN, CBG To THCV: Consumer-Centric Brands Embrace Rare Cannabinoids For Differentiation
Thursday, October 19, 2023 - 9:54am | 466At the last Benzinga Cannabis Capital Conference, industry experts discussed the rising demand for rare cannabinoids, which are lesser-known compounds found in the cannabis plant known for their unique therapeutic properties. Panelists Jerry Griffin VP of Sales & Marketing from BayMedica...
-
Balancing Between FDA Concerns And Industry Stability: CBD Industry Veterans Launch Alliance
Tuesday, September 19, 2023 - 12:31pm | 805A historic alliance of top cannabidiol (CBD) companies advocating for legislation and FDA regulation of hemp-derived CBD products as dietary supplements launched Tuesday. The alliance, ONE HEMP, includes some of the biggest names in the space, like Charlotte’s Web (OTCQX:...
-
InMed Pharmaceuticals To Acquire BayMedica, Rare Cannabinoid Manufacturer, For ~$3.66M
Monday, September 13, 2021 - 11:40am | 541InMed Pharmaceuticals (NASDAQ: INM) announced on Monday that it has entered into a definitive agreement to acquire BayMedica Inc., a private company that manufactures rare cannabinoids. Once the agreement is completed, InMed could become a global leader in the manufacturing...